We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
According to reports published in the British Medical Journal (BMJ),
a promising new malaria therapy is failing to reach African sufferers of the disease.
Already faced with the costs of harmonisation with EU directives,
Central Europe's generic drug manufacturers have acknowledged a growing threat from Indian drugmakers.
Japanese generic drug manufacturers have reported a lukewarm performance for the 2004-05 fiscal year, at a time when regulatory reform is slowly improving the sector's long-term outlook.
Agensys, Inc., a cancer biotechnology company, today announced an agreement with sanofi pasteur, the vaccines business of the sanofi-aventis Group, under which the two companies will collaborate on the research and development of vaccine products directed at colorectal and prostate cancers.
Healthcare conglomerate Mayne Group Ltd hopes to complete the demerger of its global pharmaceutical operations from its domestic healthcare businesses by the end of November.
The board of Finnish pharmaceuticals group Orion is to propose to the shareholders to spin off the drugs wholesaling and healthcare product marketing operations under Oriola-KD, Orion said in a stock exchange statement Monday.
The Solvay group on Monday said that it has hiked its stake in Solvay Pharma India Ltd to 68.85 per cent with the Netherland-based subsidiary Solvay Pharmaceuticals BV (SPBV) acquiring over 2.47 lakh shares more.
AVAX Technologies, Inc. (OTCMarket:AVXT.OB) announces the commencement of the commercial launch of M-Vax, its AC Vaccine product candidate for the treatment of melanoma, in Switzerland through its Swiss distribution partner Pro Vaccine AG based in Baar, Switzerland.
Beximco Pharmaceuticals Limited ("BPL" or the "Company"), a Bangladesh based and listed pharmaceuticals manufacturer, today announces that it is to list on AIM having successfully completed an institutional placing of global depositary receipts ("GDRs").